20.00
0.20%
-0.04
전일 마감가:
$20.04
열려 있는:
$19.94
하루 거래량:
358.06K
Relative Volume:
0.66
시가총액:
$5.47B
수익:
$1.18B
순이익/손실:
$132.61M
주가수익비율:
33.53
EPS:
0.5964
순현금흐름:
$-276.17M
1주 성능:
+9.47%
1개월 성능:
+15.81%
6개월 성능:
+0.15%
1년 성능:
-23.02%
Stevanato Group Spa Stock (STVN) Company Profile
STVN을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
STVN
Stevanato Group Spa
|
20.00 | 5.47B | 1.18B | 132.61M | -276.17M | 0.5964 |
ISRG
Intuitive Surgical Inc
|
538.55 | 192.83B | 7.87B | 2.24B | 586.00M | 4.25 |
BDX
Becton Dickinson Co
|
221.98 | 64.77B | 20.18B | 1.73B | 3.07B | 5.51 |
ALC
Alcon Inc
|
88.23 | 43.75B | 9.76B | 1.16B | 665.00M | 0.72 |
RMD
Resmed Inc
|
249.33 | 36.84B | 4.81B | 1.11B | 1.35B | 6.16 |
WST
West Pharmaceutical Services Inc
|
323.32 | 23.33B | 2.88B | 499.60M | 321.60M | 7.41 |
Stevanato Group Spa Stock (STVN) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-04-22 | 개시 | Exane BNP Paribas | Outperform |
2023-11-01 | 다운그레이드 | Jefferies | Buy → Hold |
2023-09-26 | 개시 | Stephens | Overweight |
2023-09-19 | 개시 | CJS Securities | Market Outperform |
2023-08-24 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
2021-08-10 | 개시 | BofA Securities | Buy |
2021-08-10 | 개시 | Citigroup | Buy |
2021-08-10 | 개시 | Jefferies | Buy |
2021-08-10 | 개시 | KeyBanc Capital Markets | Overweight |
2021-08-10 | 개시 | Morgan Stanley | Overweight |
2021-08-10 | 개시 | Wells Fargo | Overweight |
모두보기
Stevanato Group Spa 주식(STVN)의 최신 뉴스
Stevanato Group Will Introduce Its Large-Volume Vertiva® 10mL On - GuruFocus.com
Stevanato Group (NYSE:STVN) vs. Todos Medical (OTCMKTS:TOMDF) Financial Contrast - Defense World
Stevanato Group (NYSE:STVN) Stock Price Down 0.4%Here's Why - MarketBeat
Objective long/short (STVN) Report - Stock Traders Daily
Frank Sands Reduces Stake in Stevanato Group SpA - GuruFocus.com
Stevanato S p A : 2R Vials and Deep Cold StorageDetermining Mechanical & CCI performances - Marketscreener.com
Significant Acquisition by T. Rowe Price Investment Management i - GuruFocus.com
Pharmaceutical Visual Inspection Systems Market Report: - openPR
Stevanato: Supportive Biopharmaceutical And Diagnostic Segment And Destocking Improvement - Seeking Alpha
Stevanato Group's (NYSE:STVN) Anemic Earnings Might Be Worse Than You Think - Simply Wall St
Earnings Troubles May Signal Larger Issues for Stevanato Group (NYSE:STVN) Shareholders - Yahoo Finance
Stevanato Group to Present at Upcoming Investor Conferences - The Bakersfield Californian
Stevanato Group to Present at Three Major Healthcare Investor Conferences in Q4 | STVN Stock News - StockTitan
Auto-injectors: syringe-based and cartridge-based autoinjectors - Stevanato Group
Wellington Management Group LLP Bolsters Position in Stevanato G - GuruFocus.com
Stevanato Group S.p.A. Just Missed EarningsBut Analysts Have Updated Their Models - Simply Wall St
Medical devices assembly lines - Stevanato Group
Stevanato Group S.p.A. (NYSE:STVN) Q3 2024 Earnings Call Transcript - Insider Monkey
Citi maintains buy on Stevanato Group with $28 target - Investing.com India
Earnings call: Stevanato Group reports modest growth, eyes future recovery - Investing.com
Stevanato Group Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Customized in-vitro diagnostic consumable - Stevanato Group
In-Vitro Diagnostics (IVD) and Medical Solutions - Stevanato Group
Secondary packaging lines for the pharma industry - Stevanato Group
Drug Delivery systems and solutions - Stevanato Group
Drug containment solutions: Pharmaceutical glass containers - Stevanato Group
Stevanato Group Q3 2024 Earnings Overview - TipRanks
Citi maintains buy on Stevanato Group with $28 target By Investing.com - Investing.com UK
Stevanato Group SpA earnings missed by €0.02, revenue topped estimates - Investing.com
Stevanato Group (STVN) Q3 Earnings Match Estimates - Yahoo Canada Finance
Stevanato: Q3 Earnings Snapshot - San Antonio Express-News
Stevanato Group Reports Financial Results for the Third Quarter of 2024 - The Bakersfield Californian
(STVN) Trading Signals - Stock Traders Daily
What's Next: Stevanato Gr's Earnings Preview - Benzinga
Stevanato Group SpA (STVN) Q3 2024 Earnings Report Preview: What to Look For - Yahoo Finance
(STVN) On The My Stocks Page - Stock Traders Daily
We Think Stevanato Group (NYSE:STVN) Is Taking Some Risk With Its Debt - Simply Wall St
Stevanato Group to Report Third Quarter 2024 Financial Results on November 5, 2024 - Business Wire
Analysts Estimate Stevanato Group (STVN) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
nVerses Capital LLC Takes Position in Stevanato Group S.p.A. (NYSE:STVN) - Defense World
Stevanato Group S.p.A.: Expansion & Efficiency In Product Lines & Other Major Drivers - Smartkarma
How the (STVN) price action is used to our Advantage - Stock Traders Daily
Squarepoint Ops LLC Purchases 6,853 Shares of Stevanato Group S.p.A. (NYSE:STVN) - Defense World
Pharmaceutical Visual Inspection Systems Market: Detailed - openPR
The Manufacturers Life Insurance Company Boosts Position in Stevanato Group S.p.A. (NYSE:STVN) - MarketBeat
Check Out Stevanato Group Spa (STVN)’s Trade Data Rather Than the Analysts’ Views - SETE News
Financial Fitness Check: Examining Stevanato Group Spa (STVN)’s Key Ratios - The Dwinnex
Stevanato Group Spa (STVN)’s stock price in review: A technical analysis - US Post News
Stevanato Group Introduces Large-Volume Vertiva On-Body Delivery System - Contract Pharma
Stevanato Group Spa (STVN) Stock: A Year of Highs and Lows in the Market - The InvestChronicle
Market Recap Check: Stevanato Group Spa (STVN)’s Negative Finish at 20.00, Up/Down -6.24 - The Dwinnex
Stevanato Group Spa (STVN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):